Progression from non-radiographic to radiographic AxSpA is not the norm ● 16% progress over 5 years, 10-25% over 10 years ● Syndesmophytes in 20% over 4 years ● Male, MRI+ at baseline, response to NSAIDs are predictors of progression Jose U Scher, Review @RheumNow #ACR22 https://t.co/FatodINTfn